Human seminal alpha-inhibins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530324, A61K 3743, C07K 710

Patent

active

046249443

ABSTRACT:
The present invention discloses novel gonadal peptides with inhibin-like activity. The novel peptides include two gonadal peptides, one consisting of 52 amino acids, the other consisting of 92 amino acids. Both of these peptides were initially isolated from human seminal plasma. Both have now been chemically synthesized. The novel peptides are designated as alpha-inhibin-52 and alpha-inhibin-92. Sequence analyses show that the NH.sub.2 -terminal 31 amino acids of alpha-inhibin-52 are identical to the structure of the 31 amino acid inhibin-like peptide previously reported by Ramasharma, et al. (1984). Sequence analyses also show that the COOH-terminal 52 amino acids of alpha-inhibin-92 are identical to the structure of alpha-inhibin-52. The amino acid sequence of alpha-inhibin-92 is: ##STR1## .

REFERENCES:
Lilja, H., et al., FEBS Lett. 182: 181-184 (1985).
Ramasharma, K., et al., Science 223: 1199-1202 (1984).
Seidah, et al., FEBS Lett. 175: 349-355 (1984).
Sheth, et al., FEBS Lett. 165: 11-15 (1984).
Yamashiro, et al., Proc. Nat'l. Acad. Sci. USA 81: 5399-5402.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human seminal alpha-inhibins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human seminal alpha-inhibins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human seminal alpha-inhibins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1158611

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.